Metraipolis › archive › dc_43a6c9d2deff

Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational… — Europe PMC PMID:37915915

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37915915
DOI
10.1093/ckj/sfad184
License (as archived)
solo-consultazione
Archived
2026-10-08T00:43:30.358Z
SHA-256 of the archived text
22974ae11ffcd4766b36416d60b10944c078566acb572a8f6c0547f51511f0f7
Stable URL of this page
https://metraipolis.com/documento/dc_43a6c9d2deff

How to cite

Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational… — Europe PMC PMID:37915915 — Europe PMC (en), https://europepmc.org/article/MED/37915915 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43a6c9d2deff (Metraipolis archive dc_43a6c9d2deff, sha256 22974ae11ffcd4766b36416d60b10944c078566acb572a8f6c0547f51511f0f7)
BibTeX
@misc{dc43a6c9d2deff,
  title = {Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational… — Europe PMC PMID:37915915},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37915915},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43a6c9d2deff; sha256 22974ae11ffcd4766b36416d60b10944c078566acb572a8f6c0547f51511f0f7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37915915. Agents can read the archived copy with the MCP tool read_document.